Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to "Pseudoprogression": more than semantics

Alvin S Wong1, Martin B Lee2

  • 1Department of Haematology-Oncology, National University Cancer Institute, National University Health System, NUHS Tower Block level 7, 1E Kent Ridge Road, Singapore, 119228, Singapore. alvin_sc_wong@nuhs.edu.sg.

Cancer Immunology, Immunotherapy : CII
|August 1, 2018
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Registry of Acute Coronary Events Score Underestimates Post-Acute Coronary Syndrome Mortality among Cancer Patients.

Cancers·2023
Same author

Peritoneal Dialysis-Related Peritonitis from Carbapenemase-Producing <i>Klebsiella pneumoniae</i> with OXA-48 Type Gene.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2019
Same author

Radical radiotherapy in older patients with muscle invasive bladder cancer.

Journal of geriatric oncology·2019
Same author

Pushing the limits of immune-related response: a case of "extreme pseudoprogression".

Cancer immunology, immunotherapy : CII·2018
Same author

Chemosensitivity of Immature Teratoma in a Man.

Clinical genitourinary cancer·2017
Same author

Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.

Journal of the National Cancer Institute·2017
Same journal

CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma.

Cancer immunology, immunotherapy : CII·2026
Same journal

Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma.

Cancer immunology, immunotherapy : CII·2026
Same journal

Safety and feasibility of 5T4 antibody-coupled allogeneic NK cell therapy for solid tumors: a first-in-human phase 1 trial.

Cancer immunology, immunotherapy : CII·2026
Same journal

Time-dependent cytokine landscapes in an ex vivo microfluidic glioblastoma platform.

Cancer immunology, immunotherapy : CII·2026
Same journal

Correction: Repurposing public sarcoma multi-omics for neoantigen discovery.

Cancer immunology, immunotherapy : CII·2026
Same journal

A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice.

Cancer immunology, immunotherapy : CII·2026
See all related articles